The Swiss Working Group of Breast- and Gyneco-pathologists has surveyed inter- and intra-observer consistency of Ki-67-based proliferative fraction in breast carcinomas and showed good to very good agreement in well (G1) and poorly (G3) differentiated breast carcinomas [3]. This evidence concerns the gene MKI67 and breast carcinoma.